2024年10月31日 · COVID-19 vaccination is recommended for everyone ages 6 months and older, regardless of prior symptomatic or asymptomatic SARS-CoV-2 infection, including people with Long COVID. People who recently had SARS-CoV-2 infection may consider delaying a COVID-19 vaccine dose by 3 months from symptom onset or positive test (if infection was asymptomatic).

2023年6月3日 · Multiple COVID-19 vaccines have received emergency use authorizations (EUA) to prevent severe COVID-19 illness caused by the SARS-CoV-2 virus. They have been instrumental in controlling the severity of this pandemic and improving clinical outcomes.

2024年9月10日 · Learn how COVID-19 vaccines help our bodies develop immunity to the virus that causes COVID-19. Find out why you should get the COVID-19 vaccine and how it protects you from getting sick. COVID-19 vaccine information for people who are moderately or severely immunocompromised.

See WHO’s landscape of COVID-19 vaccine candidates for the latest information on vaccines in clinical and pre-clinical development. WHO’s COVID-19 dashboard also features the number of vaccine doses administered globally, with more detail provided on the dedicated COVID-19 vaccination dashboard.

2025年1月30日 · COVID-19 vaccines lower your risk of getting sick, seriously ill or dying from the disease. But how do the different types of COVID-19 vaccines work? Each COVID-19 vaccine causes the immune system to create proteins called antibodies. These proteins fight infection with the COVID-19 virus.

Pfizer-BioNTech and Moderna have developed mRNA-based vaccines that demonstrate more than 90% efficacy against SARS-CoV-2 clinical disease in clinical trials. This high vaccine efficacy is associated with very few adverse events, although local …

One of the main candidates for the SARS CoV-2 vaccine (mRNA-1273-based vaccine) have been developed with collaboration the National Institute of Allergy and Infectious Diseases (NIAID) and Moderna.

How COVID‑19 vaccines work. The video shows the process of vaccination, from injection with RNA or viral vector vaccines, to uptake and translation, and on to immune system stimulation and effect. Part of a series on the COVID-19 pandemic Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom. COVID-19 (disease) SARS-CoV-2 …

2020年9月23日 · To mitigate the effects of the virus on public health, the economy and society, a vaccine is urgently needed. Here I review the development of vaccines against SARS-CoV-2.

2020年12月10日 · BNT162b2 is a lipid nanoparticle–formulated, nucleoside-modified RNA vaccine that encodes a prefusion stabilized, membrane-anchored SARS-CoV-2 full-length spike protein. The primary end points...